- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01767935
Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases
A Pilot Study of The Tandem Treatment of Painful Osseous Metastases With Cryoablation Followed by Radiation Therapy
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
PRIMARY OBJECTIVES:
I. To assess the potential for efficacy and safety of combining percutaneous computed tomography (CT)-guided cryoablation and radiotherapy for the palliation of osseous metastases.
OUTLINE:
Patients undergo cryosurgery. Beginning 2 weeks later, patients undergo 1, 10, or 15 fractions of radiation therapy 5 days per week for 1-3 weeks. Treatment continues in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up at 24 hours and weeks 1-2, 4, 12, 18, and 24.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
North Carolina
-
Winston-Salem, North Carolina, Vereinigte Staaten, 27157
- Comprehensive Cancer Center of Wake Forest University
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
Pathologically (histologically or cytologically) confirmed metastatic disease with a new tumor involving or abutting bone that has the clinical and imaging features of metastatic disease
- If the nature of the metastatic disease has been previously documented, index tumor to be treated does not require further documentation (i.e., biopsy)
- Current analgesic therapies have failed (worst pain of 4 or above as measured by Brief Pain Inventory [BPI], despite analgesic therapy) OR the subject is experiencing intolerable side effects that preclude analgesic use (resulting in pain of 4 or above, as measured by BPI)
Pain must be from one or two painful metastatic sites in the bone (additional less painful metastatic sites may be present)
- Pain from the reported one or two metastatic sites must correlate with an identifiable tumor on CT, magnetic resonance imaging (MRI), or ultrasound (US) imaging
- Metastatic tumors must be amenable to cryoablation with CT or MRI
- If the index tumor is in the spine, there must be an intact cortex between the mass and the spinal canal and exiting nerve roots
- Patients must have stable use of hormonal therapy for two weeks prior to study registration and two weeks prior to cryoablation procedure)
- Stable use of pain medications (no changes within two weeks of cryoablation procedure)
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2
- Life expectancy >= 2 months
- Platelets > 50,000/mm^3
- International normalized ratio (INR) >= 1.5
- Patients may not have any debilitating medical or psychiatric illness that would preclude giving informed consent or receiving optimal treatment and follow-up
- Patients who are taking antiplatelet or anticoagulation medication (e.g., aspirin, ibuprofen, low molecular weight heparin [LMWH] preparations) must be able to discontinue such treatment prior to the cryoablation procedure for an appropriate amount of time; at least 5 days should be allowed after discontinuation of aspirin, Coumadin, clopidogrel, and dipyridamole; at least 12 hours should be allowed after discontinuation of LMWH preparations
- Patients must be clinically suitable for cryoablation therapy
- Patients must be clinically suitable for radiation therapy
- Patients must be able to understand and willing to sign a written informed consent document
Exclusion Criteria:
- Patients with a diagnosis of leukemia, lymphoma, or myeloma
- Patients with a tumor involving a weight-bearing long bone of the lower extremity with the tumor causing > 50% loss of cortical bone
- Patients who have undergone prior ablation treatment or radiation therapy of the index tumor
- Patients who have received chemotherapy within 14 days prior to and 14 days after cryoablation procedure
- Index tumor(s) causing clinical or radiographic evidence of spinal cord or cauda equine compression/effacement
- Anticipated treatment of the index tumor that would require iceball formation within 1.0 cm of the spinal cord, brain, other critical nerve structure, large abdominal vessel such as the aorta or inferior vena cava (IVC), bowel, or bladder
- Any prior surgery at the proposed treatment site OR any prior surgery involving the cryoablation-treated tumor
- Index tumor involves the skull (treatment of other painful tumors in subjects with skull tumors is not excluded)
- Patients with uncontrolled coagulopathy or bleeding disorders
- Patients who are pregnant, nursing, or who wish to become pregnant during the study
- Patients with active, uncontrolled infection
- Patients with serious medical illnesses, including any of the following: uncontrolled congestive heart failure, uncontrolled angina, myocardial infarction, cerebrovascular event within six months prior to study entry
- Patients who are concurrently participating in any other experimental studies that could affect the primary endpoint of this study
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Treatment (cryosurgery and radiation therapy)
Patients undergo cryosurgery.
Beginning 2 weeks later, patients undergo 1, 10, or 15 fractions of radiation therapy 5 days per week for 1-3 weeks.
Treatment continues in the absence of disease progression or unacceptable toxicity.
|
Nebenstudien
Andere Namen:
Unterziehe dich einer Strahlentherapie
Andere Namen:
Undergo cryosurgery
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Pain Level at 24 Hours Before Cryosurgery, as Measured by the BPI
Zeitfenster: 24 hours
|
Numerical scores (0-10) from the BPI will be used to measure pain levels.
Higher scores denotes worse outcome.
|
24 hours
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Pain Medication Level, Assessed by Changes in Narcotic Medication Usage
Zeitfenster: Baseline to 24 weeks
|
Pain medication assessments will be used to quantify any change in narcotic medication usage using the 24-hour morphine equivalent dose.
|
Baseline to 24 weeks
|
Adverse Events, Graded According to the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0
Zeitfenster: Up to 24 weeks
|
Up to 24 weeks
|
|
Pain After Cryosurgery, as Measured by the BPI
Zeitfenster: Up to 24 weeks
|
Questions #4 (least pain), #5 (average pain), and #6 (right now) from the BPI (reported on 0-10 scale) will be used as the secondary outcome measures.
Higher scores denotes worse outcome
|
Up to 24 weeks
|
Number of Participants Who Survived
Zeitfenster: Up to 24 weeks post-cryosurgery
|
Count of participants that survived.
|
Up to 24 weeks post-cryosurgery
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: David Childs, Wake Forest University Health Sciences
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- IRB00020528
- P30CA012197 (US NIH Stipendium/Vertrag)
- NCI-2012-02087 (Registrierungskennung: CTRP (Clinical Trial Reporting Program))
- CCCWFU 97212 (Andere Kennung: Wake Forest University Health Sciences)
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Schmerzen
-
Foundation IRCCS San Matteo HospitalAktiv, nicht rekrutierendGreater Trochanteric Pain Syndrome beider unteren ExtremitätenItalien
-
Gazi UniversityAbgeschlossenGesäß-Tendinitis | Greater Trochanteric Pain Syndrome beider unteren ExtremitätenTruthahn
-
Lawson Health Research InstituteNoch keine RekrutierungSchmerzen im unteren Rücken | Greater Trochanteric Pain Syndrome
-
C.R.Darnall Army Medical CenterUnbekanntGreater Trochanteric Pain SyndromeVereinigte Staaten
-
Guna S.p.aBeendetGreater Trochanteric Pain Syndrome | Pertrochantäre Fraktur | Gesäß-Tendinitis | GTPS - Greater Trochanteric Pain Syndrome | Sehnenerkrankung | GesäßmuskulaturItalien
-
Smith & Nephew, Inc.AbgeschlossenHüftschmerzen chronisch | Greater Trochanteric Pain SyndromeAustralien
-
NHS Greater Glasgow and ClydeNHS Research ScotlandRekrutierungGreater Trochanteric Pain SyndromeVereinigtes Königreich
-
Kutahya Health Sciences UniversityRekrutierungGreater Trochanteric Pain SyndromeTruthahn
-
Massachusetts General HospitalAbgeschlossenGreater Trochanteric Pain SyndromeVereinigte Staaten
-
Montefiore Medical CenterNoch keine RekrutierungGreater Trochanteric Pain SyndromeVereinigte Staaten
Klinische Studien zur Bewertung der Lebensqualität
-
Memorial Sloan Kettering Cancer CenterAbgeschlossenAszitesVereinigte Staaten
-
Kutahya Health Sciences UniversityAbgeschlossenChronischer Schmerz | Juvenile idiopathische ArthritisTruthahn
-
Maastricht UniversityTNO; Netherlands Instititute for Health Services Research; University of TwenteAbgeschlossenHerzfehler | Diabetes mellitus, Typ 2 | Chronisch obstruktive Lungenerkrankung | AsthmaNiederlande
-
Avicenna Military HospitalAbgeschlossenPostoperative GenesungMarokko
-
Akdeniz UniversityAbgeschlossen
-
Beijing Tsinghua Chang Gung HospitalRekrutierungPostoperative Komplikationen | Schlaganfall | Schwerwiegende unerwünschte kardiale Ereignisse | ModelleChina
-
Memorial Sloan Kettering Cancer CenterBeendetDie Familien oder nächsten Angehörigen von Patienten, die am MSKCC wegen nichtkutaner Plattenepithelkarzinome behandelt wurden | Oberer AerodigestivtraktVereinigte Staaten
-
Buddhist Tzu Chi General HospitalAbgeschlossen
-
Hürriyet YılmazMedipol UniversityAbgeschlossenAdoleszente idiopathische Skoliose | Gesundheitsbezogene LebensqualitätTruthahn
-
Baskent UniversityAbgeschlossenParodontitis, Erwachsener